Trial Profile
A Multicenter, Non-Randomized, Open Label Trial Of Azithromycin SR For The Treatment Of Acute Bronchitis And Secondary Infection Of Chronic Respiratory Diseases In Japan Adults.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Apr 2011
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary)
- Indications Acute bronchitis; Bacterial infections; Respiratory tract infections
- Focus Therapeutic Use
- Sponsors Pfizer
- 20 Apr 2011 Actual end date (Jun 2007) added as reported by ClinicalTrials.gov.
- 08 May 2008 New trial record.